Cara Therapeutics | CARA - Equity Capital And Reserves

Stock Price
3.93
Daily Change
-0.09 -2.24%
Monthly
2.88%
Yearly
-73.37%
Q1 Forecast
3.87

Cara Therapeutics reported $32.93M in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.





Equity Capital And Reserves Change Date
Acadia Pharmaceuticals USD 917.27M 94.89M Sep/2025
Alterity Therapeutics Limited AUD 22.81M 5.29M Jun/2023
Assertio Holdings USD 105.8M 12.5M Sep/2025
Cara Therapeutics USD 32.93M 41M Jun/2025
Cassava Sciences USD 81.57M 6.4M Sep/2025
Chugai Pharma JPY 1.89T 95.02B Sep/2025
Cipla INR 329.19B 16.3B Sep/2025
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 43.83M 6.43M Sep/2025
CSL USD 18.66B 2.75B Dec/2025
Grifols EUR 6.08B 34.72M Sep/2025
Halozyme Therapeutics USD 48.81M 455.1M Dec/2025
J&J USD 78.47B 0 Sep/2025
Neurocrine Biosciences USD 3.25B 249.5M Dec/2025
Pacira USD 693.11M 34.1M Dec/2025
Pfizer USD 92.8B 4.11B Sep/2025
RedHill Biopharma USD -4.41M 271K Jun/2025
Supernus Pharmaceuticals USD 1.06B 12.05M Dec/2025
Vanda Pharmaceuticals USD 327.19M 138.81M Dec/2025